Christopher Winter

Christopher Winter

Company: Silicon Therapeutics

Job title: Chief of R&D

Seminars:

Speaker Q&A 2:35 pm

Read more

day: Day One

Design & Development of a Systemic, Small Molecule STING Agonist: Tailoring Drug Properties and Dosing Paradigm to Optimize Therapeutic Index for the Treatment of Cancer Patients 2:10 pm

Molecular design Pharmacology of STING agonism and type I IFN driven anti-tumor immunity Biomarker and translationRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.